Responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy in patients with paroxysmal AF: data from implantable cardiac monitors

<p><strong>Aim.</strong> The aim of this study was to assess the number of responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy (AAD) in patients with paroxysmal AF through implantable cardiac monitors (ICM). <br /><strong>Metho...

Full description

Bibliographic Details
Main Authors: А. А. Симонян, В. Н. Колесников, Л. И. Виленский, Ю. С. Кривошеев, Д. И. Башта, М. Ю. Гатило, Т. А. Мызникова, З. А. Мисходжева
Format: Article
Language:English
Published: Meshalkin National Medical Research Center 2016-11-01
Series:Патология кровообращения и кардиохирургия
Subjects:
Online Access:http://journalmeshalkin.ru/index.php/heartjournal/article/view/333
_version_ 1797717727333318656
author А. А. Симонян
В. Н. Колесников
Л. И. Виленский
Ю. С. Кривошеев
Д. И. Башта
М. Ю. Гатило
Т. А. Мызникова
З. А. Мисходжева
author_facet А. А. Симонян
В. Н. Колесников
Л. И. Виленский
Ю. С. Кривошеев
Д. И. Башта
М. Ю. Гатило
Т. А. Мызникова
З. А. Мисходжева
author_sort А. А. Симонян
collection DOAJ
description <p><strong>Aim.</strong> The aim of this study was to assess the number of responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy (AAD) in patients with paroxysmal AF through implantable cardiac monitors (ICM). <br /><strong>Methods.</strong> 92 patients with paroxysmal AF were randomized into two groups: 1) AAD + ICM implantation (group I; n=46), and 2) AF catheter ablation (CA) + ICM implantation (group II; n=46), and 2). Patients with an AF% &lt; 0.5% were considered AF-free (responders). Patients with AF% &gt; 0.5% were classified as nonresponders. The follow up of this study was 24 months.<br /><strong>Results.</strong> At the end of the follow-up period 13 (28.3%) patients in AAD group and 29 (63 %) patients in CA group were responders (log-rank test; р=0.0009; HR 2,6; 95% CI [1.44-4.69], р=0.001, Cox regression). According to multivariate logistic regression analysis data, AF burden&gt;4.5% during the first two months after treatment (odds ratio [OR]=38,9; 95% confidence interval [CI], 6.2–245; P&lt;0.001), arterial hypertension (OR=12.7; 95% CI, 1.9–85.3; P=0.009) and AF duration more than 5 years (OR=8.5; 95% CI, 1.04–69.6; P=0.044) were independent predictors of AF burden progression <br /><strong>Conclusion.</strong> According to implantable cardiac monitors data, <br />in patients with paroxysmal AF radiofrequency catheter ablation as compared to antiarrhythmic drug therapy results in higher percentage of responders.</p><p>Received 10 July 2016. Accepted 22 August 2016.</p><p><strong>Funding:</strong> The study had no sponsorship. <br /><strong>Conflict of interest:</strong> The authors declare no conflict of interest.</p>
first_indexed 2024-03-12T08:40:28Z
format Article
id doaj.art-19190aa7331444dca8cd05787c405076
institution Directory Open Access Journal
issn 1681-3472
2500-3119
language English
last_indexed 2024-03-12T08:40:28Z
publishDate 2016-11-01
publisher Meshalkin National Medical Research Center
record_format Article
series Патология кровообращения и кардиохирургия
spelling doaj.art-19190aa7331444dca8cd05787c4050762023-09-02T16:49:44ZengMeshalkin National Medical Research CenterПатология кровообращения и кардиохирургия1681-34722500-31192016-11-01203828910.21688/1681-3472-2016-3-82-891047Responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy in patients with paroxysmal AF: data from implantable cardiac monitorsА. А. Симонян0В. Н. Колесников1Л. И. Виленский2Ю. С. КривошеевД. И. Башта3М. Ю. Гатило4Т. А. Мызникова5З. А. Мисходжева6Краевой клинический кардиологический диспансер, 355026, Ставрополь, Российская ФедерацияКраевой клинический кардиологический диспансер, 355026, Ставрополь, Российская ФедерацияКраевой клинический кардиологический диспансер, 355026, Ставрополь, Российская ФедерацияКраевой клинический кардиологический диспансер, 355026, Ставрополь, Российская ФедерацияКраевой клинический кардиологический диспансер, 355026, Ставрополь, Российская ФедерацияКраевой клинический кардиологический диспансер, 355026, Ставрополь, Российская ФедерацияКраевой клинический кардиологический диспансер, 355026, Ставрополь, Российская Федерация<p><strong>Aim.</strong> The aim of this study was to assess the number of responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy (AAD) in patients with paroxysmal AF through implantable cardiac monitors (ICM). <br /><strong>Methods.</strong> 92 patients with paroxysmal AF were randomized into two groups: 1) AAD + ICM implantation (group I; n=46), and 2) AF catheter ablation (CA) + ICM implantation (group II; n=46), and 2). Patients with an AF% &lt; 0.5% were considered AF-free (responders). Patients with AF% &gt; 0.5% were classified as nonresponders. The follow up of this study was 24 months.<br /><strong>Results.</strong> At the end of the follow-up period 13 (28.3%) patients in AAD group and 29 (63 %) patients in CA group were responders (log-rank test; р=0.0009; HR 2,6; 95% CI [1.44-4.69], р=0.001, Cox regression). According to multivariate logistic regression analysis data, AF burden&gt;4.5% during the first two months after treatment (odds ratio [OR]=38,9; 95% confidence interval [CI], 6.2–245; P&lt;0.001), arterial hypertension (OR=12.7; 95% CI, 1.9–85.3; P=0.009) and AF duration more than 5 years (OR=8.5; 95% CI, 1.04–69.6; P=0.044) were independent predictors of AF burden progression <br /><strong>Conclusion.</strong> According to implantable cardiac monitors data, <br />in patients with paroxysmal AF radiofrequency catheter ablation as compared to antiarrhythmic drug therapy results in higher percentage of responders.</p><p>Received 10 July 2016. Accepted 22 August 2016.</p><p><strong>Funding:</strong> The study had no sponsorship. <br /><strong>Conflict of interest:</strong> The authors declare no conflict of interest.</p>http://journalmeshalkin.ru/index.php/heartjournal/article/view/333Пароксизмальная фибрилляция предсердий • Непрерывное мониторирование сердечного ритма • Радиочастотная изоляция устьев легочных вен • Антиаритмическая терапия • Респондеры
spellingShingle А. А. Симонян
В. Н. Колесников
Л. И. Виленский
Ю. С. Кривошеев
Д. И. Башта
М. Ю. Гатило
Т. А. Мызникова
З. А. Мисходжева
Responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy in patients with paroxysmal AF: data from implantable cardiac monitors
Патология кровообращения и кардиохирургия
Пароксизмальная фибрилляция предсердий • Непрерывное мониторирование сердечного ритма • Радиочастотная изоляция устьев легочных вен • Антиаритмическая терапия • Респондеры
title Responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy in patients with paroxysmal AF: data from implantable cardiac monitors
title_full Responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy in patients with paroxysmal AF: data from implantable cardiac monitors
title_fullStr Responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy in patients with paroxysmal AF: data from implantable cardiac monitors
title_full_unstemmed Responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy in patients with paroxysmal AF: data from implantable cardiac monitors
title_short Responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy in patients with paroxysmal AF: data from implantable cardiac monitors
title_sort responders and nonresponders after catheter ablation procedure and antiarrhythmic drug therapy in patients with paroxysmal af data from implantable cardiac monitors
topic Пароксизмальная фибрилляция предсердий • Непрерывное мониторирование сердечного ритма • Радиочастотная изоляция устьев легочных вен • Антиаритмическая терапия • Респондеры
url http://journalmeshalkin.ru/index.php/heartjournal/article/view/333
work_keys_str_mv AT aasimonân respondersandnonrespondersaftercatheterablationprocedureandantiarrhythmicdrugtherapyinpatientswithparoxysmalafdatafromimplantablecardiacmonitors
AT vnkolesnikov respondersandnonrespondersaftercatheterablationprocedureandantiarrhythmicdrugtherapyinpatientswithparoxysmalafdatafromimplantablecardiacmonitors
AT livilenskij respondersandnonrespondersaftercatheterablationprocedureandantiarrhythmicdrugtherapyinpatientswithparoxysmalafdatafromimplantablecardiacmonitors
AT ûskrivošeev respondersandnonrespondersaftercatheterablationprocedureandantiarrhythmicdrugtherapyinpatientswithparoxysmalafdatafromimplantablecardiacmonitors
AT dibašta respondersandnonrespondersaftercatheterablationprocedureandantiarrhythmicdrugtherapyinpatientswithparoxysmalafdatafromimplantablecardiacmonitors
AT mûgatilo respondersandnonrespondersaftercatheterablationprocedureandantiarrhythmicdrugtherapyinpatientswithparoxysmalafdatafromimplantablecardiacmonitors
AT tamyznikova respondersandnonrespondersaftercatheterablationprocedureandantiarrhythmicdrugtherapyinpatientswithparoxysmalafdatafromimplantablecardiacmonitors
AT zamishodževa respondersandnonrespondersaftercatheterablationprocedureandantiarrhythmicdrugtherapyinpatientswithparoxysmalafdatafromimplantablecardiacmonitors